Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Shuki Usui"'
Autor:
Hiroyuki Igarashi, Hiroshi Uchino, Momoko Kanaguchi, Kaori Hisanaga, Genki Sato, Fukumi Yoshikawa, Masashi Furuta, Naohiro Washizawa, Shuki Usui, Masahiko Miyagi, Takahisa Hirose
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-10 (2023)
Abstract Objective Based on the whole-body energy metabolism and insulin action, the difference between increased excretion of carbohydrate in urine by SGLT2i and reduced same amount of oral carbohydrate intake are scarce. This study aimed to compare
Externí odkaz:
https://doaj.org/article/2de870791c864be793bc4dbf85e98e8b
Autor:
Ken Kanazawa, Hiroshi Uchino, Fumika Shigiyama, Hiroyuki Igarashi, Kayoko Ikehara, Fukumi Yoshikawa, Shuki Usui, Masahiko Miyagi, Hiroshi Yoshino, Yasuyo Ando, Naoki Kumashiro, Takahisa Hirose
Publikováno v:
Journal of Diabetes Investigation, Vol 10, Iss 4, Pp 1022-1031 (2019)
Abstract Aims/Introduction Hyperglycemia impairs energy substrate oxidation as a result of glucotoxicity. We examined whether the reduction of plasma glucose using a sodium–glucose cotransporter 2 inhibitor, in inpatient diabetes management, has an
Externí odkaz:
https://doaj.org/article/0ba193d27365436981eb3d815139f968
Autor:
Yasuyo Ando, Hiroshi Uchino, Takahisa Hirose, Masahiko Miyagi, Tomoko Nagashima, Shuki Usui, Fukumi Yoshikawa
Publikováno v:
Diabetol Int
AIMS: To improve glycemic variability (GV) is crucial in the management of multiple daily insulin (MDI) treatment in diabetes. To evaluate the GV improvement in MDI treated type 2 diabetes (T2D) with low-dose metformin 750 mg/day (LMET), which was po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e67104c9a7db05929e6321ea4d9500cd
https://doi.org/10.1007/s13340-021-00513-6
https://doi.org/10.1007/s13340-021-00513-6
Autor:
Hiroyuki Igarashi, Hiroshi Uchino, Momoko Kanaguchi, Kaori Hisanaga, Genki Sato, Fukumi Yoshikawa, Masashi Furuta, Naohiro Washizawa, Shuki Usui, Masahiko Miyagi, Takahisa Hirose
Objective: This study aimed to determine whether the carbohydrate-restricted isocaloric (CRIC) diet and sodium/glucose cotransporter-2 inhibitor (SGLT2i) differed with respect to the fasting and postprandial energy expenditure (EE) and macronutrient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18220cc663a63b4b144eb8315b3eb336
https://doi.org/10.21203/rs.3.rs-1671975/v1
https://doi.org/10.21203/rs.3.rs-1671975/v1
Autor:
Tomoko Nagashima, Naoki Kumashiro, Takahisa Hirose, Shuki Usui, Hiroshi Uchino, Yasuyo Ando, Masahiko Miyagi, Fukumi Yoshikawa
To cope the high glycemic variability (GV) is crucial in the management of multiple daily insulin (MDI) in diabetes. We compared the effect of low dose metformin 750mg/d adding vildagliptin 100mg/d (DPP4+LMET) or the high dose metformin 1500mg/d (HME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8f331eb50ddaae80041369884da3d6e
Autor:
Hiroshi Uchino, Naoki Kumashiro, Masahiko Miyagi, Takahisa Hirose, Yasuyo Ando, Ryo Iga, Ken Kanazawa, Shuki Usui, Hiroshi Yoshino
Publikováno v:
Diabetes Therapy
Introduction Optimal adjustment of basal insulin to overcome hypoglycemia and glycemic variability (GV) depends on its duration of action and peak-less profile. Owing to the ability of long-acting basal insulin to avoid hypoglycemia, we titrated pre-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc4f7dc7a030a6fac8f72a3f89e240d8
http://europepmc.org/articles/PMC5544606
http://europepmc.org/articles/PMC5544606
Autor:
Shuki Usui, Yasuo Iwasaki, Masao Moroi, Daiji Nagayama, Tatsuo Chiba, Kazuhiro Shimizu, Toshiki Fujioka, Mao Takahashi, Ichiro Tatsuno, Junichi Yamasaki, Kohji Shirai, Kosuke Nishizawa, Hideki Sugimoto, Teruo Shiba, Kaoru Sugi, Naoko Sato, Fumihiko Hara, Atsuhito Saiki, Shigeo Yamamura
Publikováno v:
International journal of cardiology. 305
Background There has been no report about outcome of pitavastatin versus atorvastatin therapy in high-risk patients with hypercholesterolemia. Methods Hypercholesterolemic patients with one or more risk factors for atherosclerotic diseases (n = 664,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef6e99cdcc2fe0ef4fb555d6445cd5e5
https://pubmed.ncbi.nlm.nih.gov/31987664
https://pubmed.ncbi.nlm.nih.gov/31987664
Autor:
Shuki Usui, Azusa Yamato, Minoru Okubo, Kaoru Nagasawa, Hiroshi Uchino, Naoki Kumashiro, Yasumichi Mori, Daijiro Yasuda, Takahisa Hirose, Akihiro Nishimura
Publikováno v:
Endocrine journal. 63(12)
Although sitagliptin and repaglinide monotherapies improve postprandial hyperglycemia, the long-term effects and safety of their combination has not been examined. In this randomized 24-week trial of Japanese patients with poor control (HbA1c 7.0-8.5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb522cef3fde899177ff07dbb87fd0ef
https://pubmed.ncbi.nlm.nih.gov/27647480
https://pubmed.ncbi.nlm.nih.gov/27647480
Autor:
Fumika, Shigiyama, Naoki, Kumashiro, Takayuki, Rikitake, Shuki, Usui, Michiko, Saegusa, Mamoru, Kitamura, Hiroshi, Uchino, Takahisa, Hirose
Publikováno v:
Endocrine journal. 63(2)
Polycystic ovary syndrome (PCOS) is common in obese women with insulin resistant type 2 diabetes for which metformin treatment is getting established in addition to clomiphene. However, lean PCOS patients are sometimes accompanied with type 1 diabete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ee50c30017cf5e66fcc541f86a8d734a
https://pubmed.ncbi.nlm.nih.gov/26765270
https://pubmed.ncbi.nlm.nih.gov/26765270
Autor:
Mariko Sue, Naoki Hiroi, Takehiko Watanabe, Tomoko Matsumoto, Saburo Nakano, Shuki Usui, Kaoru Iso, Yasushi Tojo, Koji Kuboki, Gen Yoshino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d64a1dafecfca9c543b05e2d5d51e2bc
https://doi.org/10.1210/endo-meetings.2011.part2.p10.p1-509
https://doi.org/10.1210/endo-meetings.2011.part2.p10.p1-509